Localization of a new tumor suppressor gene distal to D22S270 in colorectal carcinomas;Localisation d'un gene suppresseur de tumeur distal a D22S270 dans les cancers colorectaux

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 5, 1997, Pages 358-364

  Duriez, Cyril ^a   Schmitz, Annette ^b   Fouchet, Pierre ^b   Buecher, Bruno ^a   Thuille, Bénédicte ^a   Lerebours, Florence ^a   Léger, Raphaël ^a   Boman, Françoise ^c   Fléjou, Jean François ^d   Monges, Geneviève ^e   Paraf, François ^f   Bedossa, Pierre ^g   Sabourin, Jean Christophe ^h   Salmon, Rémy Jacques ⁱ   Laurent Puig, Pierre ^a   Thomas, Gilles ^a   Olschwang, Sylviane ^a  

^a INSERM   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c CHU NANCY BRABOIS   (France)

^d BEAUJON HOSPITAL   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f HÔPITAL BROUSSAIS   (France)

^g BICÊTRE HOSPITAL   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ INSTITUT CURIE   (France)

Author keywords

colorectal cancer; loss of heterozygosity; somatic mutation; tumor suppressor gene

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 22Q; COLORECTAL CANCER; CONTROLLED STUDY; GENE LOCATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; CELL CULTURE; CHROMOSOME 22; CHROMOSOME DELETION; CHROMOSOME MAP; COLORECTAL TUMOR; GENETICS; MUTATION;

ADENOCARCINOMA; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; COLORECTAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; TUMOR CELLS, CULTURED;

EID: 0030630983     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-21.
2. Ichii S, Horii A, Nakatsuru S, Furuyama J, Utsunomiya J, Nakamura Y. Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet 1992;1:387-90.
3. Powell SM, Zilz. N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-32.
5. Lin B, Nicolaides NC, Markowitz S. Willson JK, Parsons RE, Jen J et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995;9:48-55.
6. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW et al. Microsatellite instability and mutations of the transforming growth factor beta type 11 receptor gene in colorectal cancer, Cancer Res 1995;55:5548-50.
7. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellitc instability. Science 1995;268:1336-8.
8. Law DJ, Olschwang S, Monpezat JP, Lefrancois D, Jagelman D, Petrelli NJ et al. Concerted nonsyntenic allelic loss in human colorectal carcinoma. Science 1988;241:961-5.
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990 ;61:759-67.
10. Ionov Y, Peinado S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repealed sequences reveal a new mechanism for colonic careinogenesis. Nature 1993;363:558-60.
11. Shibata D, Peinado MA, Ionov Y, Peinado S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet 1994;6:273-81.
12. Buecher B, Schmitz A, Lerebours F, Thuille B, Thomas G, Olschwang S, Vers un allélotype de deuxième génération du cancer colique, Gastoenterol Clin Biol 1995;19:1004-10.
13. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-5.
14. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 1995;10:1581-6.
15. Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, Spirio L et al. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 1995;55:1531-9.
16. Sasaki M, Okamoto M, Sato C, Sugio K, Soejima J, Iwamact T et al. Loss of constitutional heterozygosity in colorectal tumors from patients with familial polyposis coli and those with non polyposis colorectal carcinoma. Cancer Res 1989;49:4402-6.
17. Yana I. Kurahashi H, Nakamori S, Kamcyama M, Nakamura T, Takami M et al. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers, Int J Cancer 1995;60:174-7.
18. Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T et al. Deletion mapping of the long arm of chromosome 22 in human meningioma. Int J Cancer 1995;60:178-82.
19. Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG. Localization of an ovarian tumor suppressor gene to a 0.5 cM region between D22S284 and CYP2D on chromosome 22q. Cancer Res 1996;56:719-21.
20. Englefield P, Foulkes WD, Campbell IG. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Br J Cancer 1994;70:905-7.
21. Rey JA, Bello MJ, Jimenez-Lara AM, Vaquero M, Kusak ML, de Campos JM et al. Loss of helerozygosity for distal markers on 22q in human gliomas. Int J Cancer 1992;51:703-6.
22. Ruttledge MH, Xie YG, Han FY, Peyrard M. Collins VP, Nordenskjold M et al. Deletions on chromosome 22 in sporadic meningiomas. Gene Chromosom Cancer 1994;10:122-30.
23. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 1994;54:5643-8.
24. Rouleau GA, Mérel P, Lutchman M, Sanson M, Zucman J, Marineau C et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-21.
25. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM et al. A novel mocsin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800.
26. Harada T. Irving RM, Xuereh JH, Barton DE, Hardy DG, Moffat DA et al. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma, J Neurosurg 1996;84:847-51.
27. Slavc I, MacCollin MM, Dunn M, Jones S. Sutton L, Gusella JF et al. Exon scanning for mutations of lhe NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 1995;64:243-7.
28. Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF. Gazdar AF et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 1995;55:1227-31.
29. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet -1994;3:565-8.
30. Dih C, Faure S, Fizames C, Samson D, Drouot N, Vignal A et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.
31. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P et al. The 1993-94 Genethon human genetic linkage map. Nature Genet 1994;7:246-339.
32. Collins JE, Cole CG, Smink LJ, Garrett CL, Leversha MA, Soderlund CA et al. A high-density YAC contig map of human chromosome 22. Nature 1995;377:367-79.
33. Demczuk S, Delattre O, Vignal A, Weissenbach J, Thomas G, Aurias A. Physical mapping of 30 CA repeats on human chromosome 22. Genomics 1995;27:345-7.
34. Bergstrom C, Emdin S, Roos G, Stenling R. DNA content in colorectal carcinoma: a flow cytometric study of the epithelial fraction. Anal Cell Pathol 1995;8:287-95.
35. Min D, Chang YJ, Strauss JF, Miller WL. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissue and in a patient with congenital lipoid adrenal hyperplasia. Genomics 1993;18:643-50.
36. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, et al. Allelotype of colorectal cancer. Science 1989;244:207-11.
37. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC. Kecney G et al. Human epithelial ovarian cancer allelotype. Cancer Res 1993;53:2393-8.
38. Eckner R, Ewen ME, Newsome D, Gerdes M, deCaprio JA, Lawrence JB et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 1994;8:869-84.
39. Stein RW, Corrigan M, Yaciuk P, Whelan J, Moran E. Analysis of E1A-mediated growlh regulation functions:binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J Virol 1990;64:4421-7.
40. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 1996;12:1565-9.
41. Volpert OV, Gui J, Dawson D, Bouck NP. A subunit of the peripheral human benzodiazepine receptor functions as a tumor suppressor gene (abstract). Proc Am Assoc Cancer Res 1994;A 1065.